BR9813318A - Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient - Google Patents
Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patientInfo
- Publication number
- BR9813318A BR9813318A BR9813318-7A BR9813318A BR9813318A BR 9813318 A BR9813318 A BR 9813318A BR 9813318 A BR9813318 A BR 9813318A BR 9813318 A BR9813318 A BR 9813318A
- Authority
- BR
- Brazil
- Prior art keywords
- human
- macular degeneration
- veterinary patient
- treating tumors
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
"PROCESSO DE TRATAMENTO DE TUMORES E DEGENERAçãO MACULAR EM PACIENTE HUMANO OU VETERINáRIO, COMPOSIçãO FARMACêUTICA PARA TRATAMENTO DE TUMORES E DEGENERAçãO MACULAR EM UM PACIENTE HUMANO OU VETERINáRIO". Um processo para o tratamento de tumores e degeneração macular em um paciente humano ou veterinário compreendendo a administração de um composto selecionado do grupo constituído de (I), (II), (III), (IV), (V), (VI), (VII), e uma composição farmacêutica compreendendo um veículo farmaceuticamente aceitável e um composto do grupo citado."TUMOR TREATMENT PROCESS AND MACULAR DEGENERATION IN HUMAN OR VETERINARY PATIENTS, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUMORS AND MACULAR DEGENERATION IN A HUMAN OR VETERINARY PATIENT". A process for the treatment of tumors and macular degeneration in a human or veterinary patient comprising administering a compound selected from the group consisting of (I), (II), (III), (IV), (V), (VI) , (VII), and a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the aforementioned group.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96147397A | 1997-10-31 | 1997-10-31 | |
PCT/US1998/023043 WO1999022722A2 (en) | 1997-10-31 | 1998-10-30 | Use of macrolides for the treatment of cancer and macular degeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9813318A true BR9813318A (en) | 2000-08-22 |
Family
ID=25504514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9813318-7A BR9813318A (en) | 1997-10-31 | 1998-10-30 | Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1027060A2 (en) |
JP (1) | JP2001521891A (en) |
KR (1) | KR20010031577A (en) |
CN (1) | CN1278178A (en) |
AR (1) | AR043071A1 (en) |
AU (1) | AU1206799A (en) |
BG (1) | BG104436A (en) |
BR (1) | BR9813318A (en) |
CA (1) | CA2307850A1 (en) |
HU (1) | HUP0100012A3 (en) |
IL (1) | IL135518A0 (en) |
NO (1) | NO20002189L (en) |
PL (1) | PL340604A1 (en) |
SK (1) | SK6172000A3 (en) |
TR (1) | TR200001147T2 (en) |
WO (1) | WO1999022722A2 (en) |
ZA (1) | ZA989885B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2338212T3 (en) | 2000-04-13 | 2010-05-05 | Biotica Technology Limited | HYBRID GLYCOSILATED PRODUCTS AND THEIR PRODUCTION AND USE. |
DK1539157T3 (en) | 2002-09-18 | 2013-10-07 | Univ Pennsylvania | METHOD OF INHALING CHOROIDAL NEOVASCULARIZATION |
TW200420573A (en) | 2002-09-26 | 2004-10-16 | Rib X Pharmaceuticals Inc | Bifunctional heterocyclic compounds and methods of making and using same |
US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
CA2520377A1 (en) | 2003-03-28 | 2004-10-14 | Cornell Research Foundation, Inc. | Migrastatin analog compositions and uses thereof |
US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
US8202843B2 (en) * | 2004-02-27 | 2012-06-19 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
CN108101948A (en) * | 2004-02-27 | 2018-06-01 | 瑞伯-X医药品有限公司 | Macrocyclic compound and its making and use method |
JP5149001B2 (en) | 2004-05-25 | 2013-02-20 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | Migrastatin analogues in the treatment of cancer |
EP1805161B1 (en) | 2004-09-23 | 2014-05-07 | Sloan-Kettering Institute For Cancer Research | Isomigrastatin analogs in the treatment of cancer |
AU2006213673A1 (en) | 2005-02-09 | 2006-08-17 | Santen Pharmaceutical Co., Ltd. | Formulations for ocular treatment |
AU2006270041B2 (en) | 2005-07-18 | 2011-08-18 | Minu, Llc | Enhanced ocular neuroprotection/neurostimulation |
EP1934238B1 (en) | 2005-08-24 | 2017-06-28 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
JP2009506063A (en) | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | Triazole compounds and methods for making and using the same |
JP5528708B2 (en) | 2006-02-09 | 2014-06-25 | 参天製薬株式会社 | Stable formulations and methods for preparing and using them |
KR101520408B1 (en) | 2006-03-23 | 2015-05-14 | 산텐 세이야꾸 가부시키가이샤 | Formulations and methods for vascular permeability-related diseases or conditions |
CN106317146B (en) * | 2015-06-18 | 2019-06-21 | 沈阳药科大学 | Bicyclic clarithomycin derivative and its as tumour cell increment inhibitor purposes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6461090A (en) * | 1989-10-30 | 1991-05-02 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
US5498424A (en) * | 1994-11-30 | 1996-03-12 | Klein; Ira | Method of treating obesity |
-
1998
- 1998-10-29 ZA ZA989885A patent/ZA989885B/en unknown
- 1998-10-29 AR ARP980105434A patent/AR043071A1/en unknown
- 1998-10-30 CA CA002307850A patent/CA2307850A1/en not_active Abandoned
- 1998-10-30 PL PL98340604A patent/PL340604A1/en unknown
- 1998-10-30 IL IL13551898A patent/IL135518A0/en unknown
- 1998-10-30 HU HU0100012A patent/HUP0100012A3/en unknown
- 1998-10-30 AU AU12067/99A patent/AU1206799A/en not_active Abandoned
- 1998-10-30 JP JP2000518656A patent/JP2001521891A/en not_active Withdrawn
- 1998-10-30 KR KR1020007004625A patent/KR20010031577A/en not_active Application Discontinuation
- 1998-10-30 EP EP98955206A patent/EP1027060A2/en not_active Withdrawn
- 1998-10-30 TR TR2000/01147T patent/TR200001147T2/en unknown
- 1998-10-30 SK SK617-2000A patent/SK6172000A3/en unknown
- 1998-10-30 BR BR9813318-7A patent/BR9813318A/en not_active Application Discontinuation
- 1998-10-30 WO PCT/US1998/023043 patent/WO1999022722A2/en not_active Application Discontinuation
- 1998-10-30 CN CN98810825A patent/CN1278178A/en active Pending
-
2000
- 2000-04-27 NO NO20002189A patent/NO20002189L/en unknown
- 2000-05-15 BG BG104436A patent/BG104436A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2001521891A (en) | 2001-11-13 |
WO1999022722A3 (en) | 1999-08-05 |
PL340604A1 (en) | 2001-02-12 |
IL135518A0 (en) | 2001-05-20 |
CA2307850A1 (en) | 1999-05-14 |
CN1278178A (en) | 2000-12-27 |
NO20002189D0 (en) | 2000-04-27 |
WO1999022722A2 (en) | 1999-05-14 |
BG104436A (en) | 2000-12-29 |
ZA989885B (en) | 1999-05-05 |
HUP0100012A3 (en) | 2003-07-28 |
KR20010031577A (en) | 2001-04-16 |
AR043071A1 (en) | 2005-07-20 |
EP1027060A2 (en) | 2000-08-16 |
NO20002189L (en) | 2000-06-28 |
SK6172000A3 (en) | 2001-03-12 |
HUP0100012A2 (en) | 2001-05-28 |
AU1206799A (en) | 1999-05-24 |
TR200001147T2 (en) | 2000-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9813318A (en) | Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient | |
BR9813373A (en) | Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and, processes for effecting immunosuppression and for treating or reducing the risk of reversibly obstructive airway disease in a patient | |
ATE307608T1 (en) | COMBINATION OF DOCTAXEL AND RHUMAB HER2 FOR CANCER TREATMENT | |
HUT76258A (en) | Compositions comprising dna damaging agents and p53, and methods for uses thereof | |
BR0209658A (en) | 4-Amino-5-phenyl-7-1-cyclobutyl-pyrrolo [2,3-d] pyrimidine derivatives | |
BR9715022A (en) | Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations | |
DE69127175D1 (en) | Antisense oligonucleotides for the treatment of cancer | |
DE69533112D1 (en) | USE OF FLAVOLIGNANES FOR THE PRODUCTION OF MEDICINES WITH ANTIPROLIFERATIVE ACTIVITY IN UTERUS, BREAST, EGGS | |
BG101118A (en) | Therapeutical compounds | |
BR9908510A (en) | Use of a compound, compound, process for preparing a compound, pharmaceutical composition, and process for treating a patient suffering from, or at risk for, a mycobacterial disease | |
BR9500436A (en) | Products use of a g-csf use of a tnf protein ligand process for the treatment and / or prevention of septic shock | |
BR9814419A (en) | "combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of proliferative diseases" | |
ATE334589T1 (en) | ANTI-ARRHYTHMIC COMPOSITIONS AND TREATMENT METHODS | |
PT1237562E (en) | PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES | |
MXPA00010254A (en) | The treatment of sexual dysfunction in certain patient groups. | |
PT1076561E (en) | COMBINATION THERAPY FOR THE TREATMENT OF TUMORS | |
DE69314586T2 (en) | Medicament composition containing TCF-II | |
TW374085B (en) | Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use | |
KR900017599A (en) | Pharmaceutical composition for tumor treatment | |
BR9810930A (en) | Pharmaceutical compositions of arglabine and arglabine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |